Canaccord Genuity Starts Livongo Health Inc. (LVGO) at Buy

Needham & Company Starts Livongo Health Inc. (LVGO) at Buy

August 19, 2019 6:59 AM EDT

Needham & Company analyst Scott Berg initiates coverage on Livongo Health Inc. (NASDAQ: LVGO) with a Buy rating and a price target of $42.00.

The analyst comments "We initiate coverage of Livongo Health, Inc. with a Buy rating and $42 PT based on our belief... More

SVB Leerink Starts Livongo Health Inc. (LVGO) at Outperform

August 19, 2019 6:28 AM EDT

SVB Leerink initiates coverage on Livongo Health Inc. (NASDAQ: LVGO) with a Outperform rating and a price target of $50.00.

For an analyst ratings summary and ratings history on Livongo Health Inc.... More

KeyBanc Starts Livongo Health Inc. (LVGO) at Overweight

August 19, 2019 6:22 AM EDT

KeyBanc analyst Donald Hooker initiates coverage on Livongo Health Inc. (NASDAQ: LVGO) with a Overweight rating and a price target of $46.00.

For an analyst ratings summary and ratings history on Livongo Health Inc.... More

Morgan Stanley Starts Livongo Health Inc. (LVGO) at Equalweight

August 19, 2019 4:15 AM EDT

Morgan Stanley initiates coverage on Livongo Health Inc. (NASDAQ: LVGO) with a Equalweight rating and a price target of $42.00.

For an analyst ratings summary and ratings history on Livongo Health Inc.... More

Piper Jaffray Starts Livongo Health Inc. (LVGO) at Overweight

August 19, 2019 4:12 AM EDT

Piper Jaffray analyst Sean Wieland initiates coverage on Livongo Health Inc. (NASDAQ: LVGO) with a Overweight rating and a price target of $40.00.

For an analyst ratings summary and ratings history on Livongo Health Inc.... More

Goldman Sachs Starts Livongo Health Inc. (LVGO) at Buy

August 19, 2019 3:45 AM EDT

Goldman Sachs analyst Robert Jones initiates coverage on Livongo Health Inc. (NASDAQ: LVGO) with a Buy rating and a price target of $43.00.

Sees upside thanks to the sizable addressable market.Says strong operating momentum sets the name up... More

JPMorgan Starts Livongo Health Inc. (LVGO) at Overweight

August 19, 2019 3:40 AM EDT

JPMorgan analyst Anne Samuel initiates coverage on Livongo Health Inc. (NASDAQ: LVGO) with a Overweight rating and a price target of $43.00.

Says growth profile is attractive as company is minimally penetrated in a large and growing chronic disease... More

Chardan Capital Markets Starts Livongo Health Inc. (LVGO) at Neutral

August 16, 2019 7:26 AM EDT

Chardan Capital Markets analyst Steven Wardell initiates coverage on Livongo Health Inc. (NASDAQ: LVGO) with a Neutral rating and a price target of $40.00.

For an analyst ratings summary and ratings history on Livongo Health Inc.... More